Journey™ UNI Post Market Clinical Follow-Up

Exclusion Criteria

• •1. Subject has Body Mass Index (BMI) \> 40 within 1 month of surgery.
• •2. Subjects who have received the Journey UNI UKS as part of a revision surgery.
• •3. Subject has a condition that may interfere with the unicompartmental knee arthroplasty (UKA) survival or outcome (e.g. Paget's or Charcot's disease, vascular insufficiency, muscular atrophy, uncontrolled diabetes, moderate to severe renal insufficiency or neuromuscular disease).
• •4. Subject has a known allergy to study device or one or more of its components.
• •5. Subject, in the opinion of the Principal Investigator (PI), has an emotional or neurological condition that would preempt his/her ability or willingness to participate in the study including mental illness, mental retardation, drug or alcohol abuse.
• •6. Subject is entered in another investigational drug, biologic, or device study or has been treated with an investigational product in the past 30 days.
• •7. Subject is known to be at risk for loss to follow-up, or failure to return for scheduled visits.